| 标题 |
Glofitamab plus gemcitabine and oxaliplatin (GemOx) vs rituximab (R)-GemOx in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Efficacy and safety in patient subgroups |
| 网址 | |
| DOI |
10.1182/blood-2025-3743
doi
|
| 其它 |
期刊:Blood 作者:Haifaa Abdulhaq; William Townsend; Matthew Ku; Gareth P. Gregory; Jeremy Abramson; et al 出版日期:2025-11-03 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)